Phase I Trial of Sonidegib and Pembrolizumab in Advanced Solid Tumors, including Pancreatic Cancer
The purpose of this phase I trial is to study the best dose of sonidegib when given together with pembrolizumab and to see how well they work in treating patients with solid tumor that has spread to other places in the body (advanced).
Study ID: MC1718
Trial Phase: Phase I
Trial Sponsor: Mayo Clinic
Therapies Used in This Trial: Sonidegib, Pembrolizumab